In this new report, ATscale describes the enormous gains that access to assistive technology (AT) can have in health, for the community and the economy. The figures are dramatic: investment in the provision of four assistive products – hearing aids, prostheses, eyeglasses, and wheelchairs – will result in a return on investment of 9:1.
Priority Assistive Products List (APL)

To improve access to high-quality, affordable assistive products in all countries, the World Health Organization (WHO) is introducing the Priority Assistive Products List (APL). The APL is the first stage of implementing a global commitment to improving access to assistive products – the Global Cooperation on Assistive Technology (GATE).
The APL includes 50 priority assistive products, selected on the basis of widespread need and impact on a person’s life. The list will not be restrictive; the aim is to provide the Member States with a model from which to develop a national priority assistive products list according to national need and available resources. Like the WHO Model List of Essential Medicines, the APL can also be used to guide product development, production, service delivery, market-shaping, procurement, and reimbursement policies (including insurance coverage).
The APL includes 50 priority assistive products, selected on the basis of widespread need and impact on a person’s life. The list will not be restrictive; the aim is to provide the Member States with a model from which to develop a national priority assistive products list according to national need and available resources. Like the WHO Model List of Essential Medicines, the APL can also be used to guide product development, production, service delivery, market-shaping, procurement, and reimbursement policies (including insurance coverage).
Details
Publisher Name:
World Health Organization (WHO)
Publisher Website:
https://www.who.int/
Publication Year:
2016
Languages:
English, Arabic, Chinese, French, Portuguese, Russian, Spanish, Japanese
Resource in another language:
Categories:
Evidence and data, General resources